AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Propanc Biopharma, Inc. Director's Dealing 2021

Aug 20, 2021

34906_dirs_2021-08-20_6010b964-5983-4a04-9325-aad8e70b87a5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Propanc Biopharma, Inc. (PPCB)
CIK: 0001517681
Period of Report: 2021-08-17

Reporting Person: ZELINGER JOSEF (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001	2800000	Direct